Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation?

This publication has 24 references indexed in Scilit:

• Production of prostacyclin-like substance in stroke-prone and stroke-resistant spontaneously hypertensive rats
  Prostaglandins, 1979
• HqMOLYTIC-URqMIC SYNDROME: DEFICIENCY OF PLASMA FACTOR(S) REGULATING PROSTACYCLIN ACTIVITY?
  The Lancet, 1978
• IMPLANTED VASCULAR PROSTHESES GENERATE PROSTACYCLIN
  The Lancet, 1978
• Decreased vascular prostacyclin in experimental diabetes
  Life Sciences, 1978
• PROSTACYCLIN PRODUCTION BY VASCULAR SMOOTH-MUSCLE CELLS
  The Lancet, 1978
• Prostaglandin I2 has more potent hypotensive properties than prostaglandin E2 in the normal and spontaneously hypertensive rat
  Prostaglandins, 1978
• Some investigations into the role of prostacyclin in thromboregulation
  Thrombosis Research, 1978
• PROSTACYCLIN-LIKE ACTIVITY AND BLEEDING IN RENAL FAILURE
  The Lancet, 1977
• Normal prostacyclin-like activity in vascular tissues from thrombocytopenic rats
  Thrombosis Research, 1977
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977